// App-Quantinova.ai

2092 : A phase I study of niraparib in combination with temozolomide (TMZ) in patients with advanced cancer.

Researchers

Presenter

  • Razelle Kurzrock

Principal Investigators

  • Evanthia Galanis

  • Ty Mcclure

  • Robert E. Martell

  • Shefali Agarwal

  • Derek Richard Johnson

  • Vikram Kansra

  • Keith Wilcoxen

Medical Centers

  • TESARO, Inc., Waltham, MA

  • Mayo Clinic, Rochester, MNUniversity of California, San Diego, La Jolla, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Unspecified Cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Temozolomide

  • Niraparib

Outcome

  • Positive

Study Design

  • randomized

Phase

  • I

Study Id's

  • NCT01294735

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved